Pemetrexed as Second-Line Therapy in Treating Patients With Hormone Refractory Prostate Cancer

NCT00216099 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

49

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Pemetrexed
DIETARY_SUPPLEMENT: Folic Acid
DIETARY_SUPPLEMENT: Vitamin B12

Sponsor

Christopher Sweeney, MBBS

Collaborators

[object Object]
[object Object]